An unusual alliance opens a gene and cell therapy hub outside Boston

The facility, known as Landmark Bio and based in Watertown, Mass., was born out of an unusual and broad alliance between Harvard University, MIT, and a variety of hospitals and biotech companies in the region. It was first announced in 2019, initially called the “Center for Advanced Biological Innovation and Manufacturing” and meant to address what its founders call a “bottleneck” in turning gene and cell therapy research into drug prospects.